Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhG-CSF in oral chemotherapy regimens for digestive tract tumors
ChiCTR2100054854Phase 4Recruiting
- Sponsor
- Changzhi People's Hospital
- Start
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of pegfilgrastim in neutropenia (2 arms), sponsored by Changzhi People's Hospital. Primary endpoint: Neutrophil count. Started Jan 2022; status: recruiting.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on ChiCTR2100054854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054854.